Rulemaking History for OTC Administrative Procedures Drug Products

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research

Rulemaking History for Administrative Procedures for OTC Drug Products
View by Date

Administrative Procedures for OTC Drug Products found on this page:

Note: This page links to PDF files which require the free Adobe Acrobat Reader.

**Administrative Procedures for OTC Drug Products: Drug Review Procedures**
Proposed Rule	Date	FR Citation
Proposed Rule: Review Procedures	1/5/1972	37FR85
Final Rule	Date	FR Citation
Final Rule: Review Procedures	5/11/1972	37FR9464
- Correction	5/20/1972	37FR10358
Technical Amendment: Extend comment period for proposed rules to 90 days	10/11/1977	42FR54800

**Administrative Procedures for OTC Drug Products: Category III Active Ingredients**
Advance Notice Of Proposed Rulemaking	Date	FR Citation
Advance Notice of Proposed Rulemaking: Category III active ingredients become nonmonograph in final rule	10/26/1979	44FR61608
Proposed Rule	Date	FR Citation
Proposed Rule: Continued marketing of Category III active ingredients until final rule	10/21/1975	40FR49097
Proposed Rule: Category III active ingredients become nonmonograph in final rule	5/13/1980	45FR31422
Final Rule	Date	FR Citation
Final Rule: Continued marketing of Category III active ingredients until final rule	4/12/1977	42FR19137
Final Rule: Category III active ingredients become nonmonograph in final rule	9/29/1981	46FR47730

**Administrative Procedures for OTC Drug Products: Administrative Record**
Proposed Rule	Date	FR Citation
Proposed Rule: Content and closing of administrative record	6/4/1974	39FR19878
Final Rule	Date	FR Citation
Final Rule: Content and closing of administrative record	11/8/1974	39FR39556

**Administrative Procedures for OTC Drug Products: Miscellaneous Policies**
Final Rule	Date	FR Citation
Notice: Guideline available for OTC combination drug products	11/28/1978	43FR55466
Notice: Miscellaneous policies (including feedback policy)	9/29/1981	46FR47740
Notice: Economic impact analysis available	2/8/1983	48FR5806
Notice: Policy on feedback letters	4/1/1983	48FR14050
Notice: Policy on feedback meetings	2/4/1985	50FR4916
Notice: Withdraws 136 NDAs and ANDAs	3/4/2005	70FR10651

**Administrative Procedures for OTC Drug Products: OTC/Prescription Dual Marketing**
Advance Notice Of Proposed Rulemaking	Date	FR Citation
Notice: Public hearing	4/27/2000	65FR24704
Advance Notice of Proposed Rulemaking	9/1/2005	70FR52050

Date created: December 28, 2006; Last updated: April 20, 2006